Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure
暂无分享,去创建一个
T. Videen | J. Perlmutter | J. Perlmutter | S. Moerlein | B. Racette | S. Criswell | H. Flores | A. Birke
[1] W. Martin,et al. Quantitative estimation of regional brain iron with magnetic resonance imaging. , 2009, Parkinsonism & related disorders.
[2] M. Aschner,et al. Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[3] N. Seixas,et al. Validity and Reliability of an Occupational Exposure Questionnaire for Parkinsonism in Welders , 2009, Journal of occupational and environmental hygiene.
[4] L. Pham,et al. Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre‐synaptic mechanism(s): implications to manganese‐induced parkinsonism , 2008, Journal of neurochemistry.
[5] Neurobiology in Ageing. Age-dependent decline of steady state dopamine storage capacity of human brain: An FDOPA PET study , 2008 .
[6] Pam Susi,et al. Manganese and Welding Fume Exposure and Control in Construction , 2007, Journal of occupational and environmental hygiene.
[7] Maryse Bouchard,et al. Sequelae of fume exposure in confined space welding: a neurological and neuropsychological case series. , 2007, Neurotoxicology.
[8] T. Guilarte,et al. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates , 2006, Experimental Neurology.
[9] Alexander Storch,et al. Early diagnosis of Parkinson’s disease , 2006, Journal of Neurology.
[10] T. Videen,et al. [18F]FDOPA PET and clinical features in parkinsonism due to manganism , 2005, Movement disorders : official journal of the Movement Disorder Society.
[11] Wei Zheng,et al. Alteration of serum concentrations of manganese, iron, ferritin, and transferrin receptor following exposure to welding fumes among career welders. , 2005, Neurotoxicology.
[12] W. Heiss,et al. The sensitivity of 18‐fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease , 2004, European journal of neurology.
[13] J. Antonini,et al. Health Effects of Welding , 2003, Critical reviews in toxicology.
[14] Karl Herholz,et al. The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans , 2002, Neuroscience Letters.
[15] J. Langston,et al. Novel observations with FDOPA‐PET imaging after early nigrostriatal damage , 2001, Movement disorders : official journal of the Movement Disorder Society.
[16] S Fahn,et al. Committee. Unified Parkinson’s Disease Rating Scale. , 2001 .
[17] J. Farrar,et al. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. , 2001, Neurology.
[18] R E Korczynski,et al. Occupational health concerns in the welding industry. , 2000, Applied occupational and environmental hygiene.
[19] J O Rinne,et al. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. , 2000, Archives of neurology.
[20] P Susi,et al. The use of a task-based exposure assessment model (T-BEAM) for assessment of metal fume exposures during welding and thermal cutting. , 2000, Applied occupational and environmental hygiene.
[21] A. Bonnet,et al. [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.
[22] J. W. Kim,et al. Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. , 1999, Neurotoxicology.
[23] S. Gilman,et al. Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.
[24] S. Kish,et al. Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations , 1998, Annals of neurology.
[25] Jesper L. R. Andersson,et al. How to obtain high-accuracy image registration: application to movement correction of dynamic positron emission tomography data , 1998, European Journal of Nuclear Medicine.
[26] K. Marder,et al. Altered systemic iron metabolism in Parkinson's disease , 1997, Neurology.
[27] B. Snow,et al. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication , 1997, Neurology.
[28] D J Burn,et al. Dopaminergic function in familial Parkinson's disease: A clinical and 18F‐dopa positron emission tomography study , 1997, Annals of neurology.
[29] R. Butterworth,et al. Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms , 1996, Hepatology.
[30] C. Marsden,et al. The behavioural and motor consequences of focal lesions of the basal ganglia in man. , 1994, Brain : a journal of neurology.
[31] J. Mazziotta,et al. MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.
[32] Richard S. J. Frackowiak,et al. The identification of presymptomatic parkinsonism: Clinical and {18F}dopa positron emission tomography studies in an irish kindred , 1992, Annals of neurology.
[33] J. Mazziotta,et al. Rapid Automated Algorithm for Aligning and Reslicing PET Images , 1992, Journal of computer assisted tomography.
[34] W T Yuh,et al. Neoplastic vs Inflammatory Meningeal Enhancement with Gd‐DTPA , 1990, Journal of computer assisted tomography.
[35] N. Chu,et al. Positron emission tomography in manganese intoxication , 1989, Annals of neurology.
[36] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[37] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .
[38] J RODIER,et al. Manganese Poisoning in Moroccan Miners , 1955, British journal of industrial medicine.